Home » Topics » Regulatory » Patents

Patents
RSS

Anchor Therapeutics presents new chemokine CXCR4 receptor agonists

Sep. 23, 2011

Aragon Pharmaceuticals describes new androgen receptor ligands

Sep. 22, 2011

New histone deacetylase inhibitors prepared by Millennium Pharmaceuticals

Sep. 22, 2011

Novel anticancer furoxan derivatives synthesized

Sep. 22, 2011

Boehringer Ingelheim discloses novel Mnk inhibitors

Sep. 22, 2011

University of Pittsburgh presents new anticancer agents

Sep. 22, 2011

Japanese company discloses novel fatty-acid amide hydrolase inhibitors

Sep. 21, 2011

Mitsubishi Tanabe Pharma patents new phosphodiesterase 10A inhibitors

Sep. 21, 2011

Japan Tobacco presents novel HIV integrase inhibitors

Sep. 21, 2011

Novo Nordisk claims new melanocortin receptor modulators

Sep. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...